Paper Search Console

Home Search Page Alphabetical List About Contact

Journal Title

Title of Journal: Arch Dermatol

Search In Journal Title:

Abbravation: Archives of Dermatology

Search In Journal Abbravation:

Publisher

American Medical Association

Search In Publisher:

DOI

10.1007/bf02539519

Search In DOI:

ISSN

0003-987X

Search In ISSN:
Search In Title Of Papers:

Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003-2006

Authors: Thorvardur Jon Love, Abrar A. Qureshi, Elizabeth Wood Karlson, Joel M. Gelfand, Hyon K. Choi,

Publish Date: 2011/04/01
Volume: 147, Issue:4, Pages: 419-424
PDF Link

Abstract

Frequency distribution of the metabolic syndrome components according to the presence of psoriasis. The dashed vertical line marks the cutoff for the definition of the metabolic syndrome, with the columns to the right of this line representing those patients meeting the modified National Cholesterol Education Program Adult Treatment Panel III criteria. The solid line represents the normal density plot, showing a shift toward the right among patients with psoriasis.Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011;147(4):419–424. doi:10.1001/archdermatol.2010.370Main Outcome Measures  Prevalence of the metabolic syndrome defined by the revised National Cholesterol Education Program Adult Treatment Panel III definition and odds ratios for associations after adjustment for age, sex, race/ethnicity, smoking status, and C-reactive protein levels.Results  The prevalence of the metabolic syndrome was 40% among psoriasis cases and 23% among controls. According to 2008 US census data, the projected number of patients with psoriasis aged 20 to 59 years with the metabolic syndrome was 2.7 million. The univariate and multivariate odds ratios for patients with psoriasis and the metabolic syndrome were 2.16 (95% confidence interval, 1.16 to 4.03) and 1.96 (1.01 to 3.77), respectively. The most common feature of the metabolic syndrome among patients with psoriasis was abdominal obesity, followed by hypertriglyceridemia and low levels of high-density lipoprotein cholesterol.


Keywords:

References

citation_title=Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.; citation_author=Saraceno R; citation_author=Schipani C; citation_author=Mazzotta A; citation_text=18400510; Pharmacol Res; citation_year=2008; citation_volume=57; citation_issue=4; citation_pages=290-295;


.
Search In Abstract Of Papers:
Other Papers In This Journal:


Search Result:



Help video to use 'Paper Search Console'